Stuttgart - Delayed Quote EUR
Neuren Pharmaceuticals Ltd (NK9.SG)
6.25
+0.05
+(0.81%)
At close: April 25 at 8:04:04 AM GMT+2
Loading Chart for NK9.SG
- Previous Close
6.20 - Open
6.25 - Bid 6.25 x --
- Ask 6.60 x --
- Day's Range
6.25 - 6.25 - 52 Week Range
4.62 - 10.50 - Volume
0 - Avg. Volume
0 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Feb 27, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: NK9.SG
View MorePerformance Overview: NK9.SG
Trailing total returns as of 4/25/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .
YTD Return
NK9.SG
11.97%
S&P/ASX 200 [XJO] (^AXJO)
2.34%
1-Year Return
NK9.SG
37.19%
S&P/ASX 200 [XJO] (^AXJO)
3.71%
3-Year Return
NK9.SG
37.19%
S&P/ASX 200 [XJO] (^AXJO)
6.62%
5-Year Return
NK9.SG
37.19%
S&P/ASX 200 [XJO] (^AXJO)
51.99%
Compare To: NK9.SG
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NK9.SG
View MoreValuation Measures
As of 4/25/2025
Market Cap
815.57M
Enterprise Value
690.69M
Trailing P/E
10.24
Forward P/E
65.36
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.82
Price/Book (mrq)
3.91
Enterprise Value/Revenue
5.76
Enterprise Value/EBITDA
7.00
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--